Skip to main content
. 2014 Jun 12;6(6):517–531. doi: 10.1002/wnan.1279

Fig 5.

Fig 5

The proposed mechanism of action of particle-induced cardiovascular disease. Inhalation of particles (indicated by 1 in the figure) leads to a pulmonary acute phase response (2). The accumulation of SAA in lungs leads to attraction of neutrophils. SAA is incorporated into HDL (3), replacing APO-A1 and goes into systemic circulation. SAA-HDL is deficient in reverse cholesterol transport and promotes foam cell formation from macrophages, leading to plaque progression.